PHILADELPHIA, June 12, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Inspire Medical Systems, Inc. (NYSE:INSP) ("Inspire Medical") on behalf of the company's long-term shareholders.
Recently a securities fraud complaint was filed against Inspire Medical on behalf of certain investors who purchased shares of the company's stock between May 3, 2023 and November 7, 2023. According to the complaint, during that time period Inspire Medical and certain of the company's senior executives made a series of materially false and/or misleading statements about the company's "Acceleration Program," which was reportedly designed to facilitate customers' receiving prior authorizations from doctors for Inspire Medical's sleep apnea products ("Inspire therapy") by acting as a liaison between patients and their doctors.
On November 7, 2023, Inspire Medical announced disappointing earnings results for the third quarter of ...
INSP) and Encourages Long-Term Investors to Contact the Firm>Full story available on Benzinga.com